CNBX Pharmaceuticals Inc. (CNBX)

OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
Mar 6, 2026, 4:00 PM EST
-98.97%
Market Cap 225.15K
Revenue (ttm) n/a
Net Income (ttm) -393.34K
Shares Out 1.13B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1
Average Volume 1,479,136
Open 0.0001
Previous Close 0.0002
Day's Range 0.0001 - 0.0001
52-Week Range 0.0001 - 0.0113
Beta -0.20
RSI 48.82
Earnings Date Apr 15, 2026

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc., a clinical-stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the local treatment of lateral spreading, or sessile, colorectal polyps during colonoscopy, BRST-33 for the treatment... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol CNBX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.